Background: Androgen deprivation therapy (ADT) is a standard treatment for advanced prostate cancer (PCa). However, PCa recurrence and progression rates during ADT are high. Until now, there has been no evidence regarding when progression begins. This study evaluated the gene expression of intraprostatic androgen receptor (AR) and steroidogenic enzymes in the early stages of ADT. Methods: Prostate tissue samples were taken from PCa patients with urinary retention who received ADT (ADT-PCa; n = 10) and were further subgrouped into ADT ≤12 months (n = 4) and ADT > 12 months (n = 6). The ADT-PCa tissues were then compared with BPH (n = 12) and primary (no treatment) PCa tissues (n = 16). mRNA for gene expression analysis of AR and steroidogenic enzymes was extracted from formalin-fixed paraffin embedded (FFPE) tissues and analyzed by real-time PCR. Protein expression was evaluated by immunohistochemistry with specific antibodies. Results: AR gene expression was higher in the ADT-PCa group than in the BPH or primary PCa group. Both the ADT ≤12 and > 12 months subgroups had significantly higher relative gene expression levels of AR (p < 0.01 and 0.03, respectively) than the primary PCa group. In the ADT-PCa group, AR protein expression showed an increasing trend in the ADT ≤12 months subgroup and was significantly elevated in the ADT > 12 months subgroup compared with the PCa group (100%; p < 0.01). Half (50%) of the patients in the ADT ≤12 months subgroup were found to have upregulation of AR, and one showed upregulation beginning at 3 months of ADT. A trend toward elevated relative gene expression of SRD5A3 was also apparent in the ADT groups. Conclusion: AR and steroidogenic enzymes are upregulated in ADT-PCa patients as early as 3 months, without PSA elevation. Steroidogenic enzymes, particularly SRD5A3, were also upregulated before PSA rose.

Background: Numerous tools have been developed to assess female sexual dysfunction. Several of them have also conducted validity tests. Female Sexual Function Index (FSFI) is one of these surveys that has been effectively translated into several different languages. The previous study on the translation and validation of the FSFI-6 questionnaire into Bahasa Indonesia used the original form (FSFI-19), which had many questions. Thus, this study was done to validate and translate a condensed version of the original questionnaire to make it more practicable for individuals to complete in a clinical context. Methods: FSFI-6 was translated into Bahasa Indonesia. Then the data were collected via questionnaires by 72 women in Rumah Sakit Cipto Mangunkusumo (RSCM or Mangunkusumo National Central General Hospital) during the data collection period (January 2018 until April 2018). The data obtained were processed for validity and reliability using the SPSS software program 20. The tests conducted on the data included a normality test, a validity test, descriptive analysis, and reliability testing. The r-value and the value of Cronbach’s Alpha were the parameters used to determine the validity and reliability of the questionnaire. Results: The r-value on each question in the translated FSFI-6 questionnaire was greater than 0.3, while the value of Cronbach's Alpha of the questionnaire FSFI-6 was greater than 0.6, equal to 0.831. Conclusions: The FSFI-6 questionnaire short version that has been translated into Bahasa Indonesia is valid and reliable.

No abstract